Pharmd PharmD - TRACON Pharmaceuticals VP Affairs
| TCONDelisted Stock | USD 1.60 0.55 52.38% |
Insider
Pharmd PharmD is VP Affairs of TRACON Pharmaceuticals
| Phone | 858 550 0780 |
| Web | https://www.traconpharma.com |
TRACON Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of (0.1978) % which means that it has lost $0.1978 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7701) %, meaning that it created substantial loss on money invested by shareholders. TRACON Pharmaceuticals' management efficiency ratios could be used to measure how well TRACON Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.TRACON Pharmaceuticals currently holds 968 K in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. TRACON Pharmaceuticals has a current ratio of 1.15, suggesting that it may have difficulties to pay its financial obligations when due. Note, when we think about TRACON Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| BSc FRCPath | Achilles Therapeutics PLC | 59 | |
| Dr Dubensky | Tempest Therapeutics | 66 | |
| Dan Williams | Inhibikase Therapeutics | N/A | |
| Jason Amello | Candel Therapeutics | 56 | |
| Inf MD | Candel Therapeutics | 64 | |
| Mikhail Kalinichev | Addex Therapeutics | 57 | |
| Marni Kottle | Kronos Bio | N/A | |
| Timothy Dyer | Addex Therapeutics | 56 | |
| Werner Henrichi | Addex Therapeutics | 81 | |
| Hillel MBA | Entera Bio | 46 | |
| RAC Sakai | Tempest Therapeutics | N/A | |
| Surendra Singh | Inhibikase Therapeutics | N/A | |
| HansGeorg Lerchen | Vincerx Pharma | N/A | |
| Leila MD | Pmv Pharmaceuticals | 61 | |
| MBA MD | Monopar Therapeutics | 38 | |
| Stephanie Yao | Kronos Bio | N/A | |
| Jennifer Chickering | Cyclerion Therapeutics | N/A | |
| Deepika PharmD | Pmv Pharmaceuticals | 47 | |
| Cheryl Gault | Cyclerion Therapeutics | 44 | |
| Peter Hecht | Cyclerion Therapeutics | 60 | |
| II MD | Entera Bio | 71 | |
Management Performance
| Return On Equity | -12.77 | ||||
| Return On Asset | -0.2 |
TRACON Pharmaceuticals Leadership Team
Elected by the shareholders, the TRACON Pharmaceuticals' board of directors comprises two types of representatives: TRACON Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TRACON. The board's role is to monitor TRACON Pharmaceuticals' management team and ensure that shareholders' interests are well served. TRACON Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TRACON Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shahe Garabedian, Senior Assurance | ||
| Pharmd PharmD, VP Affairs | ||
| Bonne Adams, Senior Vice President - Clinical Operations | ||
| Ya Huang, Executive Programming | ||
| James Freddo, Chief Officer | ||
| MS CPA, Chief Officer |
TRACON Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TRACON Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -12.77 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | (32.12) % | ||||
| Current Valuation | (2.64 M) | ||||
| Shares Outstanding | 2.68 M | ||||
| Shares Owned By Insiders | 2.20 % | ||||
| Shares Owned By Institutions | 11.42 % | ||||
| Number Of Shares Shorted | 166.13 K | ||||
| Price To Earning | (1.51) X |
Pair Trading with TRACON Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TRACON Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TRACON Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with TRACON Stock
Moving against TRACON Stock
| 0.58 | VERA | Vera Therapeutics | PairCorr |
| 0.52 | VCYT | Veracyte | PairCorr |
| 0.52 | DSGN | Design Therapeutics | PairCorr |
| 0.49 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.49 | DRUG | Bright Minds Biosciences | PairCorr |
The ability to find closely correlated positions to TRACON Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TRACON Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TRACON Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TRACON Pharmaceuticals to buy it.
The correlation of TRACON Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TRACON Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TRACON Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TRACON Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in TRACON Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |